DRI Healthcare Trust (TSE:DHT.UN – Get Free Report)’s stock price reached a new 52-week high during trading on Friday . The stock traded as high as C$19.14 and last traded at C$19.06, with a volume of 6573 shares changing hands. The stock had previously closed at C$18.91.
Wall Street Analysts Forecast Growth
DHT.UN has been the topic of several analyst reports. National Bank Financial raised their price target on shares of DRI Healthcare Trust from C$22.50 to C$23.50 and gave the company an “outperform” rating in a research note on Tuesday, May 19th. Stifel Nicolaus raised their target price on DRI Healthcare Trust from C$23.00 to C$24.00 and gave the company a “buy” rating in a research report on Tuesday. Scotiabank raised their price target on DRI Healthcare Trust from C$25.00 to C$30.00 and gave the company a “sector outperform” rating in a report on Tuesday, May 19th. Canaccord Genuity Group upped their price objective on shares of DRI Healthcare Trust from C$22.25 to C$23.00 and gave the stock a “buy” rating in a report on Tuesday. Finally, Raymond James Financial increased their target price on shares of DRI Healthcare Trust from C$22.50 to C$23.50 and gave the company a “strong-buy” rating in a research report on Monday. One investment analyst has rated the stock with a Strong Buy rating and four have assigned a Buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average price target of C$24.80.
Get Our Latest Analysis on DRI Healthcare Trust
DRI Healthcare Trust Stock Up 0.8%
DRI Healthcare Trust Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Monday, July 20th. Stockholders of record on Monday, July 20th will be given a dividend of $0.11 per share. The ex-dividend date is Tuesday, June 30th. This represents a $0.44 dividend on an annualized basis and a dividend yield of 2.3%. DRI Healthcare Trust’s dividend payout ratio (DPR) is -45.56%.
About DRI Healthcare Trust
DRI Healthcare Trust is managed by DRI Capital Inc DRI a pioneer in global pharmaceutical royalty monetization. We provide uniquely favorable exposure for investors in the biopharma industry managing a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world and aiming to acquire dependable patent-protected cash flow streams derived from the sales of those important drugs while limiting the risks and costs connected to drug development. DRI has developed a disciplined strategy predicated on actively sourcing royalty streams on medically necessary products and proudly work with multiple repeat deal partners.DRI Healthcare Trust is an unincorporated open-ended trust governed by the laws of the Province of Ontario pursuant to a declaration of trust dated October 21 2020 as amended.DRI Healthcare Trusts units are listed and trade on the Toronto Stock Exchange under DHT.UN in Canadian dollars and under DHT.U in U.S.
See Also
- Five stocks we like better than DRI Healthcare Trust
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
- Why the Comcast Spin-Off Won’t Fix What’s Actually Broken
Receive News & Ratings for DRI Healthcare Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DRI Healthcare Trust and related companies with MarketBeat.com's FREE daily email newsletter.
